Home › Funds › Morgan Stanley › CODX

Morgan Stanley position in CODX

CO-DIAGNOSTICS INC · Health Care

Latest position (Q2 2026)2.88K sh
Reported value held$8.92K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 137.30K $1.34M New
Q4 2021 66.65K $596.00K Reduce
Q1 2022 25.33K $156.00K Reduce
Q2 2022 505.86K $2.84M Add
Q3 2022 379.65K $1.22M Reduce
Q4 2022 367.20K $925.36K Reduce
Q1 2023 521.24K $771.43K Add
Q2 2023 28.62K $31.77K Reduce
Q3 2023 20.59K $21.82K Reduce
Q4 2023 18.75K $24.94K Reduce
Q1 2024 17.19K $19.25K Reduce
Q2 2024 20.21K $25.26K Add
Q3 2024 14.54K $18.17K Reduce
Q4 2024 21.80K $16.35K Add
Q1 2025 5.96K $1.85K Reduce
Q2 2025 5.95K $1.67K Hold
Q3 2025 5.79K $1.99K Reduce
Q4 2025 2.20K $371 Reduce
Q1 2026 88 $164 Reduce
Q2 2026 2.88K $8.92K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding CODX

All CODX fund holders →